3 Smartest Dividend Stocks to Buy Now
When the market entered a correction in February and March,…
Sell
9
CYH Quote, Financials, Valuation and Earnings
Last price:
$2.61
Seasonality move
:
-0.98%
Day range:
$2.60 - $2.74
52-week range:
$2.53 - $6.29
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.03x
P/B ratio:
--
Volume:
1.8M
Avg. volume:
2.7M
1-year change:
-22.86%
Market cap:
$375.1M
Revenue:
$12.6B
EPS (TTM):
-$3.90
Analysts' Opinion
-
Consensus RatingCommunity Health Systems has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 3 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $4.24, Community Health Systems has an estimated upside of 56.88% from its current price of $2.70.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $2.00 representing 100% downside risk from its current price of $2.70.
Fair Value
-
According to the consensus of 6 analysts, Community Health Systems has 56.88% upside to fair value with a price target of $4.24 per share.
CYH vs. S&P 500
-
Over the past 5 trading days, Community Health Systems has underperformed the S&P 500 by -0.43% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Community Health Systems does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Community Health Systems has grown year-over-year revenues for 7 quarters straight. In the most recent quarter Community Health Systems reported revenues of $3.3B.
Earnings Growth
-
Community Health Systems earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Community Health Systems reported earnings per share of -$0.53.
Enterprise value:
12.4B
EV / Invested capital:
--
Price / LTM sales:
0.03x
EV / EBIT:
21.36x
EV / Revenue:
0.98x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
103.23x
Price / Operating cash flow:
2.97x
Enterprise value / EBITDA:
11.61x
Gross Profit (TTM):
$5.3B
Return On Assets:
-3.61%
Net Income Margin (TTM):
-4.08%
Return On Equity:
--
Return On Invested Capital:
-4.92%
Operating Margin:
8.73%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $12.2B | $12.5B | $12.6B | $3.2B | $3.3B | |
| Gross Profit | $4.9B | $5.1B | $5.3B | $1.3B | $1.4B | |
| Operating Income | $720M | $869M | $843M | $249M | $285M | |
| EBITDA | $1.7B | $1.5B | $1.1B | $525M | $413M | |
| Diluted EPS | $0.33 | -$1.03 | -$3.90 | $0.35 | -$0.53 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $4.5B | $3.5B | $3.1B | $3.2B | $3.3B | |
| Total Assets | $16B | $15.2B | $14.7B | $14.5B | $14.1B | |
| Current Liabilities | $2.8B | $2.4B | $2.2B | $2.1B | $2.3B | |
| Total Liabilities | $17.1B | $16B | $15.4B | $15.3B | $15.4B | |
| Total Equity | -$1.1B | -$810M | -$734M | -$824M | -$1.3B | |
| Total Debt | $12.2B | $12.1B | $11.6B | $11.5B | $11.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $300M | $210M | $480M | $90M | $216M | |
| Cash From Investing | -$259M | -$26M | -$275M | $180M | -$143M | |
| Cash From Financing | -$430M | -$264M | -$206M | -$323M | -$69M | |
| Free Cash Flow | -$115M | -$257M | $120M | -$20M | $107M | |
CYH
Sector
Market Cap
$375.1M
$37M
Price % of 52-Week High
42.93%
43.14%
Dividend Yield
0%
0%
Shareholder Yield
19.02%
-1.03%
1-Year Price Total Return
-22.86%
-43.58%
Beta (5-Year)
1.717
0.746
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$2.72
200-day SMA
Sell
Level
$4.04
Bollinger Bands (100)
Sell
Level
2.87 - 3.79
Chaikin Money Flow
Buy
Level
844.9K
20-day SMA
Sell
Level
$2.79
Relative Strength Index (RSI14)
Sell
Level
41.27
ADX Line
Sell
Level
17.78
Williams %R
Neutral
Level
-52.9412
50-day SMA
Sell
Level
$3.12
MACD (12, 26)
Buy
Level
0.76
25-day Aroon Oscillator
Sell
Level
-40
On Balance Volume
Sell
Level
-2.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.7266)
Sell
CA Score
(Annual)
Level (-2.7617)
Buy
Beneish M-Score
(Annual)
Level (-2.7497)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (2.8014)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.
Stock Forecast FAQ
In the current month, CYH has received 2 Buy ratings 3 Hold ratings, and 1 Sell ratings. The CYH average analyst price target in the past 3 months is $4.24.
-
Where Will Community Health Systems Stock Be In 1 Year?
According to analysts, the consensus estimate is that Community Health Systems share price will rise to $4.24 per share over the next 12 months.
-
What Do Analysts Say About Community Health Systems?
Analysts are divided on their view about Community Health Systems share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Community Health Systems is a Sell and believe this share price will drop from its current level to $2.00.
-
What Is Community Health Systems's Price Target?
The price target for Community Health Systems over the next 1-year time period is forecast to be $4.24 according to 6 Wall Street analysts, 2 of them rate the stock a Buy, 1 rates the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is CYH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Community Health Systems is a Hold. 3 of 6 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of CYH?
You can purchase shares of Community Health Systems via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Community Health Systems shares.
-
What Is The Community Health Systems Share Price Today?
Community Health Systems was last trading at $2.61 per share. This represents the most recent stock quote for Community Health Systems. Yesterday, Community Health Systems closed at $2.70 per share.
-
How To Buy Community Health Systems Stock Online?
In order to purchase Community Health Systems stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Buy
80
CORT alert for Apr 1
Corcept Therapeutics [CORT] is down 15.45% over the past day.
Sell
16
PCVX alert for Apr 1
Vaxcyte [PCVX] is down 2.99% over the past day.
Sell
47
RGC alert for Apr 1
Regencell Bioscience Holdings [RGC] is down 4.08% over the past day.
